New approaches in the diagnostic procedure of malignant pleural effusions

Oncology Reports

Volumn 12, Issue 1, 2004, Pages 79-83

  Terracciano, Daniela ^a   Di Carlo, Angelina ^a   Papa, Paolino ^a   Cicalese, Marcello ^a   Maietta, Pierpaolo ^a   Cecere, Ciriaco ^a   Mariano, Angela ^a   Macchia, Vincenzo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Carbohydrate antigen 15 3; Carbohydrate antigen 19 9; Carcinoembryonic antigen; Lewis carbohydrate antigens; Pleural effusions

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; BREAST TUMOR; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; NEOPLASM; PLEURA EFFUSION;

ADULT; AGED; BREAST NEOPLASMS; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; TUMOR MARKERS, BIOLOGICAL;

EID: 21644443884     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.1.79     Document Type: Article

References (23)

1. Sahn SA: The pleura. Am Rev Respir Dis 138: 184-234, 1988.
2. Fenton KN and Richardson JD: Diagnosis and management of malignant pleural effusion. Am J Surg 170: 69-74, 1995.
3. Marel M, Stastny B, Melinova L, Svandova E and Light RW: Diagnosis of pleural effusions. Experience with clinical studies 1986 to 1990. Chest 107: 1598-1603, 1995.
4. Menzies R and Charbonneau M: Thoracoscopy for the diagnosis of pleural disease. Am Intern Med 114: 271-276, 1991.
5. Serre G, Daste G, Vincent C, Mauduyt MA and Soleilhavoup JP: Diagnostic approach to the patient with pleural effusion: cytology analysis of pleural fluid. In: International Trends in General Thoracic Surgery. Volume 6. Deslauriers I and Lacquet LK (eds). The CV Mosby Co., St. Louis, pp35-45, 1990.
6. Miedouge M, Rouzaud P, Salama G, Pujazon MC, Vincent C, Mauduyt MA, Reyre J, Charles P and Serre G: Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer 81: 1059-1065, 1999. (Pubitemid 29516152)
7. Ferrer I, Villarino MA, Encabo G, Felip E, Bermejo B, Vila S and Orriols R: Diagnostic utility of Cyfra 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 86: 1488-1495, 1999. (Pubitemid 29489782)
8. Zimmerman RL, Fogt F and Goonewardene S: Diagnostic value of a second generation Ca 15-3 antibody to detect adenocarcinoma in body cavity effusions. Cancer 90: 230-234, 2000. (Pubitemid 30660110)
9. Alatas F, Alatas O, Metintas M, Colak O, Harmanci E and Demir S: Diagnosic value of CEA, Ca 15-3, Ca 19.9, Cyfra 21-1, NSE and TSA assay in pleural effusions. Lung Cancer 31: 9-16, 2001. (Pubitemid 32012598)
10. Kuralay F, Tokgoz Z and Comlekci A: Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin. Clin Chim Acta 300: 43-55, 2000. (Pubitemid 30665773)
11. Pastan I, Lovelace ET, Gallo MG, Rutherford AV, Magnani IL and Willingham MC: Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. Cancer Res 51: 3781-3787, 1991.
12. Mariano A, Di Carlo A, Pastan I and Macchia V: Analysis of glycoproteins in cancers and normal tissues reactive with monoclonal antibodies B3 and B1. Int J Oncol 16: 549-553, 2000.
13. Pastan I: Targeted therapy of cancer with recombinant immunotoxin. Biochim Biophys Acta 1333: C1-C6, 1997.
14. 4. Nature 227: 680-685, 1970.
15. Bradford MM: A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
16. Paramothayan NS and Barron J: New criteria for the differentation between transudates and exudates. J Clin Pathol 55: 69-71, 2002. (Pubitemid 34081687)
17. Vives M, Porcel JM, Vicente De Vera C, Ribelles E and Rubio M: A study of light's criteria and possible modification for distinguishing exudative from transudative pleural effusions. Chest 109: 1503-1507, 1996.
18. Mezger J, Permanetter W, Gerbes AL, Wilmanns W and Lamerz R: Tumour associated antigens in diagnosis. J Clin Pathol 41: 633-643, 1988.
19. Villena V, Lopez-Encuentra A, Echave-Sustaeta J, Martin-Escribano P, Ortuno-De-Solo B and Estenoz-Alfaro J: Diagnostic value of Ca 72-4, carcinoembryonic antigen, Ca 15-3 and Ca 19-9 assay in pleural fluid. A study of 207 patients. Cancer 78: 736-740, 1996. (Pubitemid 26268602)
20. Romero R, Fernandez C, Arriero JM, Espasa A, Candela A, Martin C and Sanchez-Paya J: CEA, Ca 15-3 and cyfra 21-1 in serum and pleural fluid of patients with pleural effusion. Eur Respir J 9: 17-23, 1996. (Pubitemid 26038814)
21. Villena V, Lopez-Encuentra A, Echave-Sustaeta I, Martin-Escribano P, Ortuno-De-Solo B and Estenoz-Alfaro J: Diagnostic value of Ca 549 in pleural fluid. Comparison with CEA, Ca 15-3 and Ca 72.4. Lung Cancer 40: 289-294, 2003. (Pubitemid 36627708)
22. Fukuda M: Possible roles of tumor-associated carbohydrate antigens. Cancer Res 56: 2237-2244, 1996.
23. Di Carlo A, Mariano A, D'Alessandro V, Belli G, Romano G and Macchia V: Evaluation of epidermal growth factor receptor, carcinoembryonic antigen and Lewis carbohydrate antigens in human colorectal and liver neoplasias. Oncol Rep 8: 387-392, 2001. (Pubitemid 33758099)